tradingkey.logo

Polyrizon Ltd

PLRZ
View Detailed Chart

1.120USD

+0.080+7.69%
Close 09/19, 16:00ETQuotes delayed by 15 min
4.70MMarket Cap
--P/E TTM

Polyrizon Ltd

1.120

+0.080+7.69%
Intraday
1m
30m
1h
D
W
M
D

Today

+7.69%

5 Days

-6.67%

1 Month

+8.74%

6 Months

+96.49%

Year to Date

-48.39%

1 Year

0.00%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

Its valuation is considered fairly valued,and institutional recognition is very low. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
301 / 506
Overall Ranking
552 / 4720
Industry
Biotechnology & Medical Research

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 95.02.
Fairly Valued
The company’s latest PE is -2.09, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 715.00 shares, decreasing 16.57% quarter-over-quarter.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..
Ticker SymbolPLRZ
CompanyPolyrizon Ltd
CEOMr. Tomer Izraeli
Websitehttps://polyrizon-biotech.com/
KeyAI